Overview
BAX market data
Price History
BAX price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$1.87 Diluted earnings per share over the trailing twelve months.
- Beta
- 0.65 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- 0.1% Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- -9.3% Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $15.73 – $30.00 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $14.4B · P/B 1.60 · P/S 1.25.
Company News
FDA Classifies Baxter's Removal Of Certain Duo-Vent Solution Set Lots As Class I Recall Over Air Bubble Risk; Baxter Says No Serious Injuries Or Deaths ReportedBenzinga · Aug 13, 2026, 4:10 PM
Baxter International Says Anita Zielinski To Resign As Interim CFO, Effective September 15, 2026Benzinga · Aug 4, 2026, 9:41 PM
8-K filing — BAXTER INTERNATIONAL INC (BAX)SEC EDGAR · Aug 4, 2026, 9:22 PM
Shares of medical device and equipment companies are trading higher as investors assess the key takeaways from last week's financial results across the sector.Benzinga · Aug 3, 2026, 6:13 PM
TD Cowen Maintains Hold on Baxter International, Raises Price Target to $29Benzinga · Jul 31, 2026, 4:12 PM
Wells Fargo Maintains Equal-Weight on Baxter International, Raises Price Target to $23Benzinga · Jul 31, 2026, 2:35 PM
Stifel Maintains Hold on Baxter International, Raises Price Target to $28Benzinga · Jul 31, 2026, 1:40 PM
Citigroup Upgrades Baxter International to Neutral, Raises Price Target to $28Benzinga · Jul 31, 2026, 12:35 PM
Baxter Jumps After Q2 Beat, Boosted 2026 Guidance Reflects Turnaround ProgressBenzinga · Jul 30, 2026, 3:33 PM
Baxter International shares are trading higher after the company reported better-than-expected Q2 financial results and raised its FY26 guidance above estimates.Benzinga · Jul 30, 2026, 12:19 PM